Ahmed SA - Search Results

1

Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity.

Hale M, Oyler G, Swaminathan S, Ahmed SA. Hale M, et al. Among authors: ahmed sa. J Biol Chem. 2011 Jan 21;286(3):1802-11. doi: 10.1074/jbc.M110.146464. Epub 2010 Oct 20. J Biol Chem. 2011. PMID: 20961849 Free PMC article.

2

Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A.

Kumaran D, Rawat R, Ludivico ML, Ahmed SA, Swaminathan S. Kumaran D, et al. Among authors: ahmed sa. J Biol Chem. 2008 Jul 4;283(27):18883-91. doi: 10.1074/jbc.M801240200. Epub 2008 Apr 22. J Biol Chem. 2008. PMID: 18434312 Free article.

3

The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Mizanur RM, Frasca V, Swaminathan S, Bavari S, Webb R, Smith LA, Ahmed SA. Mizanur RM, et al. Among authors: ahmed sa. J Biol Chem. 2013 Aug 16;288(33):24223-33. doi: 10.1074/jbc.M113.451286. Epub 2013 Jun 18. J Biol Chem. 2013. PMID: 23779108 Free PMC article.

4

Substrate binding mode and its implication on drug design for botulinum neurotoxin A.

Kumaran D, Rawat R, Ahmed SA, Swaminathan S. Kumaran D, et al. Among authors: ahmed sa. PLoS Pathog. 2008 Sep 26;4(9):e1000165. doi: 10.1371/journal.ppat.1000165. PLoS Pathog. 2008. PMID: 18818739 Free PMC article.

5

Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling.

Kumar G, Kumaran D, Ahmed SA, Swaminathan S. Kumar G, et al. Among authors: ahmed sa. Acta Crystallogr D Biol Crystallogr. 2012 May;68(Pt 5):511-20. doi: 10.1107/S0907444912003551. Epub 2012 Apr 17. Acta Crystallogr D Biol Crystallogr. 2012. PMID: 22525749

6

Tyrosine phosphorylation of botulinum neurotoxin protease domains.

Toth S, Brueggmann EE, Oyler GA, Smith LA, Hines HB, Ahmed SA. Toth S, et al. Among authors: ahmed sa. Front Pharmacol. 2012 Jun 4;3:102. doi: 10.3389/fphar.2012.00102. eCollection 2012. Front Pharmacol. 2012. PMID: 22675300 Free PMC article.

7

Inhibition of catalytic activities of botulinum neurotoxin light chains of serotypes A, B and E by acetate, sulfate and calcium.

Mizanur RM, Gorbet J, Swaminathan S, Ahmed SA. Mizanur RM, et al. Among authors: ahmed sa. Int J Biochem Mol Biol. 2012;3(3):313-21. Epub 2012 Sep 25. Int J Biochem Mol Biol. 2012. PMID: 23097747 Free PMC article.

8

Medical applications of clostridia and clostridial toxins.

Hale ML, Cai S, Ahmed SA. Hale ML, et al. Among authors: ahmed sa. J Toxicol. 2012;2012:678963. doi: 10.1155/2012/678963. Epub 2012 Oct 18. J Toxicol. 2012. PMID: 23125855 Free PMC article. No abstract available.

9

N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B.

Jayaraman S, Eswaramoorthy S, Ahmed SA, Smith LA, Swaminathan S. Jayaraman S, et al. Among authors: ahmed sa. Biochem Biophys Res Commun. 2005 Apr 29;330(1):97-103. doi: 10.1016/j.bbrc.2005.02.123. Biochem Biophys Res Commun. 2005. PMID: 15781237

10

Development of a Coxiella burnetii culture method for high-throughput assay to identify host-directed therapeutics.

Miller CN, Khan M, Ahmed SA, Kota K, Panchal RG, Hale ML. Miller CN, et al. Among authors: ahmed sa. J Microbiol Methods. 2020 Feb;169:105813. doi: 10.1016/j.mimet.2019.105813. Epub 2019 Dec 17. J Microbiol Methods. 2020. PMID: 31862458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

905 results

Search Page